New drug offers hope against TB

Volunteers have begun receiving an experimental tuberculosis drug that developers hope will turn the tide against the disease, which kills 2 million people each year.

    Some TB strains have become resistant to available drugs
    The experimental therapy is the product of a consortium of non-profit organisations, US government agencies and two drug makers who have come together to beat a disease that disproportionately afflicts people in developing countries.

    Led by the New York-based Global Alliance for TB Drug Development, the group announced on Tuesday that it has begun testing 53 healthy volunteers at a clinic in Lincoln, Nebraska, to determine whether the drug is safe.

    Researchers hope to have the drug approved for mass distribution within six years, said Dr Mel Spigelman, head of the alliance's research and development.

    Antibiotics can cure tuberculosis, but treatment involves a regimen of up to four drugs administered for six months.

    Resistant strains

    Many strains of tuberculosis have become resistant to current drugs.

    "It has the promise to be active against these bugs that are resistant"

    Dr Mel Spigelman, head of Global Alliance's R&D

    "It has the promise to be active against these bugs that are resistant," Spigelman said.

    The experimental drug, dubbed PA-824, is owned by the biotechnology company Chiron Corporation.

    Chiron sold rights to the drug for a "modest fee" to Global Alliance in 2002 and agreed to allow the non-profit alliance to distribute it for free in developing countries.

    Chiron retains commercial rights to the drug in developed countries.

    SOURCE: Agencies


    YOU MIGHT ALSO LIKE

    Why some African Americans are moving to Africa

    Escaping systemic racism: Why I quit New York for Accra

    African-Americans are returning to the lands of their ancestors as life becomes precarious and dangerous in the USA.

    Why Jerusalem is not the capital of Israel

    Why Jerusalem is not the capital of Israel

    No country in the world recognises Jerusalem as Israel's capital.

    Who benefits from Pakistan's loss of US aid?

    Aid and tirade in Pakistan: The back story

    Trump's decision to cut off aid has benefited other players on Pakistan's political scene.